Antibody Engineering & Therapeutics US is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Kazuo Suzuki
CEO and President at A-CLIP Institute Co., Ltd

Profile

Prof. Kazuo SUZUKI obtained PhD degree at Tokyo Metropolitan University Graduate School of Science, Biology in 1978. He has held a number of important positions as Chief in National Institute of Nutrition-Tokyo, Dept. of Pathology, RERF-Hiroshima which he met Dr. Tomisaku KAWASAKI finding Kawasaki disease in 1967, Dept. of Antibiotics, National Institute of Infectious Diseases-Tokyo, Professor of Dept. of Immunology, Chiba University Graduate School of Medicine, and Professor of University of Tokyo. He is now President and CEO, A-CLIP Institute, Co., Ltd. and Professor of Teikyo University - Director of Asia International Institute of Infectious Disease Control for research in infectious diseases and vasculitis. During these research works he published 221 original papers in peer reviewed international journals. Regarding experiences, he is one of the persons responsible for studies on A/H5N1flu, ARDS, vasculitis and Kawasaki disease. He is a steering committee member of ANCA Workshop. He also works as some leaders of MHLW projects in recombinant IgGs and JST projects in quantum dots and VasSF development. Now, he is developing VasSF as a new drug for vasculitis including blood vessel diseases in A-CLIP Institute, Co., Ltd. Japan. Visit Website.

Agenda Sessions

  • VasSF As a New Drug Development for Vasculitis including Blood Vessel Diseases - Recombinant Single-chain Fragment Variable Region of Human IgG

    ,